Search Results - Timple, Noel

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Discovery of KIN-3248, An Irreversible, Next Generation FGFR Inhibitor for the Treatment of Advanced Tumors Harboring FGFR2 and/or FGFR3 Gene Alterations

    Discovery of KIN-3248, An Irreversible, Next Generation FGFR Inhibitor for the Treatment of Advanced Tumors Harboring FGFR2 and/or FGFR3 Gene Alterations by Tyhonas, John S., Arnold, Lee D., Cox, Jason M., Franovic, Aleksandra, Gardiner, Elisabeth, Grandinetti, Kathryn, Kania, Robert, Kanouni, Toufike, Lardy, Matthew, Li, Chun, Martin, Eric S., Miller, Nichol, Mohan, Adithi, Murphy, Eric A., Perez, Michelle, Soroceanu, Liliana, Timple, Noel, Uryu, Sean, Womble, Scott, Kaldor, Stephen W.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    The Discovery of Exarafenib (KIN-2787): Overcoming the Challenges of Pan-RAF Kinase Inhibition

    The Discovery of Exarafenib (KIN-2787): Overcoming the Challenges of Pan-RAF Kinase Inhibition by Chen, Young K., Kanouni, Toufike, Arnold, Lee D., Cox, Jason M., Gardiner, Elisabeth, Grandinetti, Kathryn, Jiang, Ping, Kaldor, Stephen W., Lee, Catherine, Li, Chun, Martin, Eric S., Miller, Nichol, Murphy, Eric A., Timple, Noel, Tyhonas, John S., Vassar, Angie, Wang, Tim S., Williams, Richard, Yuan, Ding, Kania, Robert S.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    BIIB021, a synthetic Hsp90 inhibitor, has broad application against tumors with acquired multidrug resistance

    BIIB021, a synthetic Hsp90 inhibitor, has broad application against tumors with acquired multidrug resistance by Zhang, Hong, Neely, Laura, Lundgren, Karen, Yang, Yong‐Ching, Lough, Rachel, Timple, Noel, Burrows, Francis

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Abstract 2674: Antitumor activity of KIN-2787, a next-generation pan-RAF inhibitor, in preclinical models of human RAF/RAS mutant melanoma

    Abstract 2674: Antitumor activity of KIN-2787, a next-generation pan-RAF inhibitor, in preclinical models of human RAF/RAS mutant melanoma by Miller, Nichol L. G., Wang, Tim S., Severson, Paul, Jiang, Ping, Perez, Michelle, Timple, Noel, Kanouni, Toufike, Franovic, Aleksandra, Martin, Eric S., Murphy, Eric

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Design, synthesis, and biological evaluation of pyrazolopyrimidine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (part I)

    Design, synthesis, and biological evaluation of pyrazolopyrimidine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (part I) by Zhang, Lin, Fan, Junhua, Chong, Jer-Hong, Cesena, Angela, Tam, Betty Y.Y., Gilson, Charles, Boykin, Christina, Wang, Deping, Aivazian, Dikran, Marcotte, Doug, Xiao, Guangqing, Le Brazidec, Jean-Yves, Piao, Jinhua, Lundgren, Karen, Hong, Kevin, Vu, Khang, Nguyen, Khanh, Gan, Liang-Shang, Silvian, Laura, Ling, Leona, Teng, Min, Reff, Mitchell, Takeda, Nicole, Timple, Noel, Wang, Qin, Morena, Ron, Khan, Samina, Zhao, Shuo, Li, Tony, Lee, Wen-Cherng, Taveras, Arthur G., Chao, Jianhua

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: